The financial consequences of many medical business decisions are little better than guesses unless based upon detailed knowledge of medical production costs. MBA’s Activity-Based Cost Analysis uses proprietary, patent-pending protected processes to allocate provider operating costs across RBRVS defined production. The knowledge of medical procedure costs and profits informs and empowers physicians, executives, and consultants for improved operational and strategic decision-making.

A client medical group presented with opportunities for major expansions of services that included several medical directorships, used MBA's Activity-Based Cost Analysis to determine clinical services costs related to those expansions. Actual activity-based costs and projected relative value units (RVUs) service volumes were used as the basis for medical directorship agreements assuring fair, empirically-substantiated, physician compensation.